Postdoctoral Associate- Alzheimer's Gene Therapy
We are developing gene therapy for Alzheimer's disease targeting the earliest stages of dementia. Our approach leverages AAV as a Trojan horse to overcome the challenges of delivering peptide inhibitors across the blood-brain barrier. Proof-of-principle in genetically engineered mouse models shows the power of this strategy.
Discovers, discusses, and deploys new research ideas towards the goal of making gene therapy a reality for neurological disease.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
New Breakthrough Paves the Way for Extending Human Lifespan – Scientists Successfully Transfer Longevity GeneThe successful transfer of a gene that produces HMW-HA paves the way for improving the health and lifespan of humans, too. In a groundbreaking endeavor, scientists at the University of Rochester have successfully transferred a longevity gene from naked mole rats to mice, leading to enhanced health
Weiterlesen »
Intermittent Fasting May Help Slow Alzheimer's, Scientists SayAlzheimer's currently affects around one in nine US adults over the age of 65, and the disorder is expected to become even more prevalent in the future.
Weiterlesen »
Gene Simmons Reflects on KISS Farewell Tour & What's Next for HimET spoke with the rocker at his Gene Simmons Birthday Party charity bash.
Weiterlesen »
How Gene-Edited Insects Are Providing Food, Fuel and Waste DisposalCompanies are recruiting black soldier flies and mealworms as a protein source in animal feed, fertilizer, biofuels and even as ingredients for burgers and shakes
Weiterlesen »
- Biberach an der Riß, Baden-Württemberg (DE) job with Boehringer Ingelheim International GmbHJoin Boehringer Ingelheim as a Postdoctoral researcher and be a part of our vibrant scientific community. Apply with your scientific proposal today!
Weiterlesen »